Thomas D. Anderson's most recent trade in Zevra Therapeutics Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | Thomas D. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |